top of page
Browse by category
Search
By-Band-Sleeve trial: RYGB betters LSG on weight loss and quality-of-life outcomes
Outcomes from the By-Band-Sleeve trial has confirmed the safety and effectiveness of bariatric and metabolic surgery (BMS) and that...
SOUL trial: Oral semaglutide 14 mg demonstrated superior reduction in risk of CV events
e full results from the SOUL cardiovascular outcomes trial, investigating the effects of Rybelsus (semaglutide) tablets 14 mg on reducing...
Analysis of SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV events
Analysis of the SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV...
Expanding access to anti-obesity medications delivers 13% return on investment for society
A USC Schaeffer Center white paper entitled, ‘Lifetime Social Returns From Expanding Access to Anti-Obesity Medication’, finds expanded...
First patient dosed in study of Corbus’ next-generation CB1 Inverse Agonist CRB-913 for the treatment of obesity
The first patient has been dosed in Corbus Pharmaceuticals in the single ascending dose/multiple ascending dose (SAD/MAD) portion of the...
Vivani issues positive preclinical weight loss data for NPM-139 semaglutide implant
Vivani Medical has announced promising preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic...
BMS demonstrates superior efficacy over non-surgical treatments in managing obesity and associated metabolic disorders
A systematic review and meta-analysis of randomised clinical trials (RCTs) underscores the superior efficacy of bariatric and metabolic...
Sucralose alters brain activity related to hunger and increases appetite, especially in people with obesity
A study from the Keck School of Medicine of USC found that sucralose, a common sugar substitute, alters brain activity related to hunger...
Bioequivalence of RT-114, delivered orally via the RaniPill capsule, to subcutaneously administered PG-102
Rani Therapeutics has announced pharmacokinetic and pharmacodynamic data from a preclinical study evaluating RT-114, a GLP-1/GLP-2 dual...
Why obesity takes away the pleasure of eating
A study by scientists at the University of California, Berkeley, suggests that pleasure in eating, even eating junk food, is key to...
Browse by tag
bottom of page